Life Sciences Group Of The Year: Gibson Dunn
Lawyers at Gibson Dunn & Crutcher LLP have spent the past year working on major deals for pharmaceutical giants, including Merck's $11.5 billion acquisition of a cancer and rare disease biotech...To view the full article, register now.
Already a subscriber? Click here to view full article